Atlas FDA

MODIFICATION OF TRICYCLIC SERUM TOX EIA ASSAY

FDA 510(k) clearance K983268 · decided 1998-11-18

Clearance details

K-number
K983268
Device name
MODIFICATION OF TRICYCLIC SERUM TOX EIA ASSAY
Applicant
Diagnostic Reagents, Inc.
Decision
Substantially Equivalent
Date received
1998-09-17
Decision date
1998-11-18
Days to decision
62 days
Clearance type
Traditional
Product code
LFH
Device class
2
Regulation number
862.3910
Medical specialty
Clinical Toxicology
Advisory committee
Clinical Toxicology
Location
Sunnyvale, CA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Diagnostic Reagents

The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Alinity c Tricyclic Antidepressants Reagent Kit (K231020)Microgenics Corporation2023-11-17
DRI TM Tricyclics Serum Tox Assay (K213875)Microgenics Corporation2022-12-21
ACCUSIGN TCA, BIOSIGN TCA, STAUS DS TCA (K981801)Princeton BioMeditech Corp.1998-08-25
TRICYCLICS SERUM TOX ASSAY (K961393)Diagnostic Reagents, Inc.1996-06-12
AXSYM TRICYCLIC ANTIDEPRESSANTS (K953761)Abbott Laboratories1995-11-22

Recalls involving this device

No recalls on record reference this clearance.